NCT03666052

Brief Summary

1.1 Research objectives A.To observe the fundus changes in the posterior pole (morphology, thickness, asymmetry, blood flow density, etc) with the myopia progression. B.To observe morphological changes in choroid and peripheral region of retina with myopia progression. C. To observe changes of visual function (contrast sensitivity, Microperimetry, etc) with myopia progression. D. To detect the susceptibility genes related to high myopia and myopic fundus changes; to test the levels of Vitamin D, riboflavin, transforming growth factor(TGF), insulin-like growth factor(IGF), fibroblast growth factor(FGF), etc. E. To observe the changes of living quality, psychology, behavior and social activities of high myopic children. 1.2 Research design Prospective cohort study. After completing the baseline survey, the planned follow-up frequency is once a year. 1.3 Research cycle 2018.06\~2038.06 (at least). 1.4 Expected results A. Registration completed a study of high myopia research for children and adolescents covering around 3,000 people; B. Establish a database information management system and workflow SOP(standard operating procedure)file for the study of high myopia registration in children and adolescents; C. Further clarify the changes in the retinal, choroidal and scleral tissue structures, blood flow density, etc. in the macular area and the optic disc; D. Revealing the changes of the retina, choroid and other tissues in the peripheral area with the progression of myopia; E. To clarify the relationship between changes in the fundus structure and changes in visual function in the posterior pole; F. Further clarify the etiology and pathogenesis of high myopia, pathological myopia and myopic fundus lesions, and identify the relationship between high myopia and pathological myopia; G. From the perspectives of society, behavior and psychology, the effects of high myopia and pathological myopia on children and adolescents will be fully demonstrated. 2\. Research object 2.1 General characteristics of the research object Based on the refraction development archive system that has been constructed in Shanghai, the list of children and adolescents with high myopia was selected from the database of children's refractive development archives information in Shanghai. Children of different ages with high myopia must meet the following conditions:

  1. 1.4-5 years old, equivalent spherical error(SE) ≤ -4.0 diopter(D);
  2. 2.6-8 years old, equivalent spherical error(SE) ≤ -6.0 diopter(D);
  3. 3.9-18 years old, equivalent spherical error(SE) ≤ -8.0 diopter(D).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
150mo left

Started Sep 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Sep 2018Sep 2038

First Submitted

Initial submission to the registry

August 5, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 11, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

September 16, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
19 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2038

Expected
Last Updated

September 18, 2018

Status Verified

September 1, 2018

Enrollment Period

12 months

First QC Date

August 5, 2018

Last Update Submit

September 15, 2018

Conditions

Keywords

children and adolescenthigh myopiaprospective study

Outcome Measures

Primary Outcomes (16)

  • spherical equivalent(SE)

    SE=spherical power+1/2\*cylindrical power

    June 31, 2038

  • axial length(AL)

    collected by IOL master

    June 31, 2038

  • corneal curvature

    collected by IOL master

    June 31, 2038

  • lens thickness(LT)

    collected by Pentacam

    June 31, 2038

  • anterior chamber depth(ACD)

    collected by Pentacam

    June 31, 2038

  • vitreous chamber depth(VCD)

    collected by Pentacam

    June 31, 2038

  • visual function of macula

    using a Microperimetry

    June 31, 2038

  • SS-OCT

    morphology of fundus( en-face and B-scan images)

    June 31, 2038

  • SS-OCTA

    blood flow of retina and choroid

    June 31, 2038

  • myopic retinopathy

    using color fundus photography and ultra-wide fundus photography

    June 31, 2038

  • concentration of microelement in plasma

    concentration of microelement in plasma

    June 31, 2038

  • concentration of growth factor(GF) in plasma

    concentration of growth factor in plasma

    June 31, 2038

  • concentration of IGF-1 in plasma(IGF-1)

    concentration of IGF-1 in plasma

    June 31, 2038

  • concentration of testosterone in plasma

    concentration of testosterone in plasma

    June 31, 2038

  • concentration of estradiol in plasma

    concentration of estradiol in plasma

    June 31, 2038

  • whole exome sequency of DNA

    find related mutations of myopia

    June 31, 2019

Secondary Outcomes (9)

  • uncorrected visual acuity

    June 31, 2038

  • corrected visual acuity

    June 31, 2038

  • best corrected visual acuity

    June 31, 2038

  • spherical power

    June 31, 2038

  • cylindrical power

    June 31, 2038

  • +4 more secondary outcomes

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

1 General characteristics of the research object Based on the refraction development archive system that has been constructed in Shanghai, the list of children and adolescents with high myopia was selected from the database of children's refractive development archives information in Shanghai. Children of different ages with high myopia must meet the following conditions: 1. 4-5 years old, equivalent spherical error ≤ -4.0 D; 2. 6-8 years old, equivalent spherical error ≤ -6.0 D; 3. 9-18 years old, equivalent spherical error ≤ -8.0 D. 2 Sample size A total of 1.25 million children and adolescents are currently registered, 4,006 (0.32%) of which meet the entry requirements. Among the 4\~5 year olds, there are 815 people with SE≤-4D; 842 people with SE≤-6 D among the 6\~8 year olds; 2349 people with SE≤-8D among the people aged 9 and over . Taking into account the 50% non-response and the proportion of the exclusion, the initial registration number is about 2,000.

You may qualify if:

  • Children and adolescents between the ages of 4 and 18 years old, SE ≤ -4 D under 5 years old, SE ≤ -6 D at 6-8 years old, SE ≤ -8 D over 9 years old;
  • No eye disease, good general condition, can cooperate with the examiner;
  • Obtaining the consent of the child and his/her guardian;
  • Long-term residence in this city, there is no plan to move out of this city in the short term.

You may not qualify if:

  • Amblyopia (best corrected visual acuity (BCVA) less than 0.8 for children over 6 years old, BCVA less than 0.63 for children 6 years old and younger) and strabismus;
  • Secondary myopia, genetic disease or connective tissue-related myopia;
  • Moderate or severe ptosis;
  • Congenital cataract, glaucoma;
  • Other fundus diseases other than myopic related fundus lesions;
  • Intraocular or refractive surgery history;
  • The refractive medium is turbid, and it is impossible to take a clear fundus image;
  • Unable to cooperate with fundus image shooting and other examination;
  • Do not receive cycloplegia or have contraindications;
  • Poor overall condition, unable to follow up for a long time;
  • The child or the guardian refuses to participate in the research;
  • Other cases in which the researcher judges that it is not suitable for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Eye Disease Prevention & Treatment Center

Shanghai, Shanghai Municipality, 200040, China

Location

Related Publications (1)

  • Deng J, Xu X, Pan CW, Wang J, He M, Zhang B, Yang J, Hou XW, Zhu Z, Borchert G, Chen J, Cheng T, Yu S, Fan Y, Liu K, Zou H, Xu X, He X. Myopic maculopathy among Chinese children with high myopia and its association with choroidal and retinal changes: the SCALE-HM study. Br J Ophthalmol. 2024 May 21;108(5):720-728. doi: 10.1136/bjo-2022-321839.

Biospecimen

Retention: SAMPLES WITH DNA

saliva and blood sample 5-10ml

Study Officials

  • Xu Xian

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2018

First Posted

September 11, 2018

Study Start

September 16, 2018

Primary Completion

September 1, 2019

Study Completion (Estimated)

September 1, 2038

Last Updated

September 18, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations